These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15662077)

  • 41. Extracorporal therapy with AN69 membranes in combination with ACE inhibition causing severe anaphylactoid reactions: still a current problem?
    Kammerl MC; Schaefer RM; Schweda F; Schreiber M; Riegger GA; Krämer BK
    Clin Nephrol; 2000 Jun; 53(6):486-8. PubMed ID: 10879671
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hyperkalemia with concomitant watery diarrhea: an unusual association.
    Taylor JG; Zwillich CW; Kaehny WD; Levi M; Popovtzer MM
    Am J Kidney Dis; 2003 Aug; 42(2):E9-12. PubMed ID: 12900845
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Angiotensin converting enzyme inhibitor induced hyperkalaemic paralysis.
    Dutta D; Fischler M; McClung A
    Postgrad Med J; 2001 Feb; 77(904):114-5. PubMed ID: 11161080
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Acute renal failure from ACE inhibitors in elderly patients: are there any prognostic indicators?].
    Summa R; Campanella M; Nanni MR; Stuard S; Di Luzio V
    G Ital Nefrol; 2004; 21(1):84-5. PubMed ID: 15356852
    [No Abstract]   [Full Text] [Related]  

  • 45. New strategies for treatment of heart failure with aldosterone antagonists and the risk of hyperkalaemia.
    Cruz CS; Cruz LS; Domingues GS; Souza CA
    Expert Opin Drug Saf; 2005 Jul; 4(4):677-88. PubMed ID: 16011447
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute renal failure during lisinopril and losartan therapy for proteinuria.
    Hanevold CD
    Pharmacotherapy; 2006 Sep; 26(9):1348-51. PubMed ID: 16945058
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Late drug-induced hyperkalemia in a patient with congestive heart failure].
    Konopa J; Bułło B; Rutkowski B
    Przegl Lek; 2005; 62(7):732-3. PubMed ID: 16463712
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk factors associated with a high velocity of the development of hyperkalaemia in hospitalised patients.
    Indermitte J; Burkolter S; Drewe J; Krähenbühl S; Hersberger KE
    Drug Saf; 2007; 30(1):71-80. PubMed ID: 17194172
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Extreme hyperkalaemia caused by concomitant use of a NSAID and an ace inhibitor in an elderly patient.
    Rogulj D; Hauptfeld M; Iskra MS; Zorko VK; Strasek M
    Arh Hig Rada Toksikol; 2010 Jun; 61(2):241-5. PubMed ID: 20587399
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Safety of Angiotensin-converting enzyme inhibitors in patients with insect venom allergies.
    Stumpf JL; Shehab N; Patel AC
    Ann Pharmacother; 2006 Apr; 40(4):699-703. PubMed ID: 16569814
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Let's read the domestic literature. ACE-inhibitors and spironolactone-induced hyperkalemia].
    Radó J
    Orv Hetil; 2002 Aug; 143(31):1868; author reply 1868. PubMed ID: 12187583
    [No Abstract]   [Full Text] [Related]  

  • 52. [CMF-ECG 19/Solution. Electrolyte disturbance].
    Brunckhorst CB
    Praxis (Bern 1994); 2007 Oct; 96(43):1691-2. PubMed ID: 18019181
    [No Abstract]   [Full Text] [Related]  

  • 53. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
    Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
    Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical factors associated with hyperkalemia in patients with congestive heart failure.
    Ramadan FH; Masoodi N; El-Solh AA
    J Clin Pharm Ther; 2005 Jun; 30(3):233-9. PubMed ID: 15896240
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [ACE inhibitors and kidney function].
    Berg KJ
    Tidsskr Nor Laegeforen; 1992 Feb; 112(4):461-2. PubMed ID: 1553690
    [No Abstract]   [Full Text] [Related]  

  • 56. Angioedema from angiotensin-converting enzyme (ACE) inhibitor treated with complement 1 (C1) inhibitor concentrate.
    Nielsen EW; Gramstad S
    Acta Anaesthesiol Scand; 2006 Jan; 50(1):120-2. PubMed ID: 16451161
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Consequences of fluid loss in patients treated with ACE inhibitors.
    McMurray J; Matthews DM
    Postgrad Med J; 1987 May; 63(739):385-7. PubMed ID: 2823245
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Additional side effects of ACE inhibitors.
    Graves JW
    Am Fam Physician; 2002 Dec; 66(11):2048. PubMed ID: 12484685
    [No Abstract]   [Full Text] [Related]  

  • 59. [Life threatening drug-induced hyperkaliemia--case report].
    Konopa J; Bullo B; Rutkowski B
    Pol Arch Med Wewn; 2006 Mar; 115(3):238-42. PubMed ID: 18468430
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preventable sudden death in patients receiving angiotensin converting enzyme inhibitors and loop/potassium sparing diuretic combinations.
    Johnston RT; de Bono DP; Nyman CR
    Int J Cardiol; 1992 Feb; 34(2):213-5. PubMed ID: 1737674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.